Enter the first few characters of Company and click 'Go'

Audited Results of Balaxi Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Operating Income	108.14	101.29	86.87	45.63	13.60
Manufacturing Expenses	0.04	0	0	0	0
Personnel Expenses	4.04	2.90	1.95	1.76	0.90
Selling Expenses	0.21	0.40	0.07	0.10	0.02
Administrative Expenses	4.93	3.81	2.63	3.73	0.81
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	91.32	84.03	67.98	39.17	11.96
Operating Profit	16.82	17.26	18.89	6.46	1.63
Other Recurring Income	6.60	2.75	1.81	2.81	0.81
Adjusted PBDIT	23.42	20.01	20.70	9.27	2.44
Financial Expenses	0.46	0.06	0.01	0	0
Depreciation	0.52	0.25	0.09	0.01	0
Other Write offs	0	0	0	0	0
Adjusted PBT	22.45	19.70	20.60	9.27	2.44
Tax Charges	6.23	5.03	5.46	2.77	0.47
Adjusted PAT	16.22	14.67	15.13	6.50	1.97
Non Recurring Items	0	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	16.22	14.67	15.13	6.50	1.97
Equity Dividend	0.50	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	52.34	36.61	21.95	6.81	0.32

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article